ABT

Q: What is the price of Abbott (ABT) today?

The current price of Abbott (ABT) is $ 102.93, representing a -16.95% gain over the past year. The stock began the year trading around $ 125.29 and is currently priced at $ 102.93. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Abbott (ABT) pay dividends?

In the last year, Abbott (ABT) distributed dividends in the month of February, totaling $ 0.63. The Dividend Yield for the last 12 months is 2.34%.

Q: Is Abbott (ABT) a good investment?

Abbott (ABT) is currently trading at $ 102.93 with a P/E ratio of 27.37%. This represents a 2,479% premium compared to its historical average P/E. Over the past year, the stock has gained -16.95 and paid $ 0.63 in dividends, resulting in a dividend yield of 2.34%. The total shareholder return over the same period was -16.95%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Abbott Laboratories

Price

$ 102.93

return (12m)

-16.95%

p/e

27.37

p/bv

3.48

DIVIDEND YIELD

2.34%

ABT price

ABT

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ABT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.32%

3 months

-17.34%

1 year

-16.95%

2 years

-4.25%

5 years

-6.24%

10 years

191.55%

Fundamentals ABT

review the fundamentals of Abbott shares

P/E

27.37

Sector: -2.15 Industry: 0.38

P/S (PSR)

4.03

Sector: 1.92 Industry: 2.43

P/BV

3.48

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

2.34%

Sector: - Industry: -

ROA

0.00%

Sector: -25.33% Industry: -23.48%

ROE

12.73%

Sector: -29.65% Industry: -31.19%

ROIC

10.73%

Sector: -418.66% Industry: -76.94%

NET MARGIN

14.72%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

56.42%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

18.17%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

15.36

Sector: -0.40 Industry: 1.11

EV/EBIT

20.10

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

Sector: 1.13 Industry: 1.20

BVPS

29.48

Sector: 3.83 Industry: 5.09

EPS

3.75

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

0.58%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-1.60%

Sector: - Industry: -

FAIR VALUE OF Abbott ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 102.93

Fair Value

$ 0.00

Upside/Downside Return potential.

-51.54%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ABT

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%
CI	10.45	0.00	0.00%	2.26%	$ 71.83 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ABT Historical Dividends

current DY: 2.34%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/15/2026	05/15/2026	0,63000000
Dividends	01/15/2026	02/13/2026	0,63000000
Dividends	10/15/2025	11/17/2025	0,59000000
Dividends	07/15/2025	08/15/2025	0,59000000
Dividends	04/15/2025	05/15/2025	0,59000000
Dividends	01/15/2025	02/14/2025	0,59000000
Dividends	10/15/2024	11/15/2024	0,55000000
Dividends	07/15/2024	08/15/2024	0,55000000
Dividends	04/15/2024	05/15/2024	0,55000000
Dividends	01/12/2024	02/15/2024	0,55000000
Dividends	10/13/2023	11/15/2023	0,51000000
Dividends	07/14/2023	08/15/2023	0,51000000
Dividends	04/14/2023	05/15/2023	0,51000000
Dividends	01/13/2023	02/15/2023	0,51000000
Dividends	10/14/2022	11/15/2022	0,47000000
Dividends	07/15/2022	08/15/2022	0,47000000
Dividends	04/15/2022	05/16/2022	0,47000000
Dividends	01/14/2022	02/15/2022	0,47000000
Dividends	10/15/2021	11/15/2021	0,45000000
Dividends	07/15/2021	08/16/2021	0,45000000
Dividends	04/15/2021	05/17/2021	0,45000000
Dividends	01/15/2021	02/16/2021	0,45000000
Dividends	10/15/2020	11/16/2020	0,36000000
Dividends	07/15/2020	08/17/2020	0,36000000
Dividends	04/15/2020	05/15/2020	0,36000000
Dividends	01/15/2020	02/14/2020	0,36000000
Dividends	10/15/2019	11/15/2019	0,32000000
Dividends	07/15/2019	08/15/2019	0,32000000
Dividends	04/15/2019	05/15/2019	0,32000000
Dividends	01/15/2019	02/15/2019	0,32000000
Dividends	10/15/2018	11/15/2018	0,28000000
Dividends	07/13/2018	08/15/2018	0,28000000
Dividends	04/13/2018	05/15/2018	0,28000000
Dividends	01/12/2018	02/15/2018	0,28000000
Dividends	10/13/2017	11/15/2017	0,26500000
Dividends	07/14/2017	08/15/2017	0,26500000
Dividends	04/14/2017	05/15/2017	0,26500000
Dividends	01/13/2017	02/15/2017	0,26500000
Dividends	10/14/2016	11/15/2016	0,26000000
Dividends	07/15/2016	08/15/2016	0,26000000
Dividends	04/15/2016	05/16/2016	0,26000000
Dividends	01/15/2016	02/16/2016	0,26000000
Dividends	10/15/2015	11/15/2015	0,24000000
Dividends	07/15/2015	08/15/2015	0,24000000
Dividends	04/15/2015	05/15/2015	0,24000000
Dividends	01/15/2015	02/13/2015	0,24000000
Dividends	10/15/2014	11/15/2014	0,22000000
Dividends	07/15/2014	08/15/2014	0,22000000
Dividends	04/15/2014	05/15/2014	0,22000000
Dividends	01/15/2014	02/15/2014	0,22000000
Dividends	10/15/2013	11/15/2013	0,14000000
Dividends	07/15/2013	08/15/2013	0,14000000
Dividends	04/15/2013	05/15/2013	0,14000000
Dividends	01/15/2013	02/15/2013	0,14000000
Dividends	10/15/2012	11/15/2012	0,51000000
Dividends	07/13/2012	08/15/2012	0,51000000
Dividends	04/13/2012	05/15/2012	0,51000000
Dividends	01/13/2012	02/15/2012	0,48000000
Dividends	10/14/2011	11/15/2011	0,48000000
Dividends	07/15/2011	08/15/2011	0,48000000
Dividends	04/15/2011	05/16/2011	0,48000000
Dividends	01/14/2011	02/15/2011	0,44000000
Dividends	10/15/2010	11/15/2010	0,44000000
Dividends	07/15/2010	08/15/2010	0,44000000
Dividends	04/15/2010	05/15/2010	0,44000000
Dividends	01/15/2010	02/15/2010	0,40000000
Dividends	10/15/2009	11/15/2009	0,40000000
Dividends	07/15/2009	08/15/2009	0,40000000
Dividends	04/15/2009	05/15/2009	0,40000000
Dividends	01/15/2009	02/15/2009	0,36000000
Dividends	10/15/2008	11/15/2008	0,36000000
Dividends	07/15/2008	08/15/2008	0,36000000
Dividends	04/15/2008	05/15/2008	0,36000000
Dividends	01/15/2008	02/15/2008	0,32500000
Dividends	10/15/2007	11/15/2007	0,32500000
Dividends	07/13/2007	08/15/2007	0,32500000
Dividends	04/13/2007	05/15/2007	0,32500000
Dividends	01/12/2007	02/15/2007	0,29500000
Dividends	10/13/2006	11/15/2006	0,29500000
Dividends	07/14/2006	08/15/2006	0,29500000
Dividends	04/13/2006	05/15/2006	0,29500000
Dividends	01/13/2006	02/15/2006	0,27500000
Dividends	10/14/2005	11/15/2005	0,27500000
Dividends	07/15/2005	08/15/2005	0,27500000
Dividends	04/15/2005	05/15/2005	0,27500000
Dividends	01/14/2005	02/15/2005	0,26000000
Dividends	10/15/2004	11/15/2004	0,26000000
Dividends	07/15/2004	08/15/2004	0,26000000
Dividends	04/15/2004	05/15/2004	0,26000000
Dividends	01/15/2004	02/15/2004	0,24500000
Dividends	10/15/2003	11/15/2003	0,24500000
Dividends	07/15/2003	08/15/2003	0,24500000
Dividends	04/15/2003	05/15/2003	0,24500000
Dividends	01/15/2003	02/15/2003	0,23500000
Dividends	10/15/2002	11/15/2002	0,23500000
Dividends	07/15/2002	08/15/2002	0,23500000
Dividends	04/15/2002	05/15/2002	0,23500000
Dividends	01/15/2002	02/15/2002	0,21000000
Dividends	10/15/2001	11/15/2001	0,21000000
Dividends	07/13/2001	08/15/2001	0,21000000
Dividends	04/12/2001	05/15/2001	0,21000000
Dividends	01/15/2001	02/15/2001	0,19000000
Dividends	10/13/2000	11/15/2000	0,19000000
Dividends	07/14/2000	08/15/2000	0,19000000
Dividends	04/14/2000	05/15/2000	0,19000000
Dividends	01/14/2000	02/15/2000	0,17000000
Dividends	10/15/1999	11/15/1999	0,17000000
Dividends	07/15/1999	08/15/1999	0,17000000
Dividends	04/15/1999	05/15/1999	0,17000000
Dividends	01/15/1999	02/15/1999	0,15000000
Dividends	10/15/1998	11/15/1998	0,15000000
Dividends	07/15/1998	08/15/1998	0,15000000
Dividends	04/15/1998	05/15/1998	0,15000000
Dividends	01/15/1998	02/15/1998	0,13500000
Dividends	10/15/1997	11/15/1997	0,13500000
Dividends	07/15/1997	08/15/1997	0,13500000
Dividends	04/15/1997	05/15/1997	0,13500000
Dividends	01/15/1997	02/15/1997	0,12000000
Dividends	10/15/1996	11/15/1996	0,12000000
Dividends	07/15/1996	08/15/1996	0,12000000
Dividends	04/15/1996	05/15/1996	0,12000000
Dividends	01/15/1996	02/15/1996	0,10500000
Dividends	10/13/1995	11/15/1995	0,10500000
Dividends	07/14/1995	08/15/1995	0,10500000
Dividends	04/14/1995	05/15/1995	0,10500000
Dividends	01/13/1995	02/15/1995	0,09500000
Dividends	10/14/1994	11/15/1994	0,09500000
Dividends	07/15/1994	08/15/1994	0,09500000
Dividends	04/15/1994	05/15/1994	0,09500000
Dividends	01/15/1994	02/15/1994	0,08500000
Dividends	10/15/1993	11/15/1993	0,08500000
Dividends	07/15/1993	08/15/1993	0,08500000
Dividends	04/15/1993	05/15/1993	0,08500000
Dividends	01/15/1993	02/15/1993	0,07500000
Dividends	10/15/1992	11/15/1992	0,07500000
Dividends	07/15/1992	08/15/1992	0,07500000
Dividends	04/15/1992	05/15/1992	0,07500000
Dividends	01/15/1992	02/15/1992	0,06250000
Dividends	10/15/1991	11/15/1991	0,06250000
Dividends	07/15/1991	08/15/1991	0,06250000
Dividends	04/15/1991	05/15/1991	0,06250000
Dividends	01/15/1991	02/15/1991	0,05250000
Dividends	10/15/1990	11/15/1990	0,05250000
Dividends	07/13/1990	08/15/1990	0,05250000
Dividends	04/12/1990	05/15/1990	0,05250000
Dividends	01/15/1990	02/15/1990	0,04375000

ABOUT Abbott

Abbott Laboratories

Average Investor10 user rating

5.0 (94 people)

United States

126 years

Founded: 1900

1949

Time since IPO - 77 years

107.000

Employees

Abbott Laboratories operates in the Health Care sector, within the Medical Devices and Diagnostics industry. Founded in 1888 by Wallace Calvin Abbott, the company began with the goal of producing standardized pharmaceutical formulations based on scientific methods and quality control.

Today, Abbott maintains a diversified healthcare portfolio spanning diagnostics, medical devices, nutrition, and branded generic pharmaceuticals.

Its core divisions include:

Diagnostics.
Medical Devices.
Nutrition.
Established Pharmaceuticals.

Key products and solutions include:

Clinical laboratory and molecular diagnostic systems.
Rapid and point-of-care testing technologies.
Continuous glucose monitoring (CGM) systems.
Cardiovascular and structural heart devices.
Pediatric and adult nutritional products.

Abbott operates in more than 160 countries, supported by manufacturing facilities, research centers, and global distribution networks. Its customer base includes hospitals, laboratories, physicians, healthcare systems, and patients.

Performance is influenced by healthcare regulation, reimbursement policies, demographic trends such as population aging, chronic disease prevalence, innovation cycles, and competition within the global medical technology market.

Abbott shares trade on the New York Stock Exchange (NYSE) under the ticker ABT.

History and Development

Abbott was founded in 1888 in Chicago, where Wallace C. Abbott developed standardized drug formulations derived from medicinal plant extracts.

Throughout the 20th century, the company expanded beyond pharmaceuticals into diagnostics and medical devices, building research capabilities and international operations.

Over time, Abbott diversified through acquisitions and internal innovation, strengthening its presence in cardiovascular devices, diabetes care, and laboratory diagnostics.

A major milestone in recent years was the acquisition of St. Jude Medical, which expanded Abbott’s cardiovascular portfolio. The company also advanced its continuous glucose monitoring systems, positioning itself as a key player in diabetes management.

In recent years, Abbott has increased investment in rapid testing technologies, cardiovascular innovation, and global manufacturing capacity, reinforcing its position as a diversified medical technology company with broad international reach.

Additional Information

Abbott Laboratories (United States) is listed on the NYSE and has a market capitalization of $178.54 Billions, with shareholders equity totaling $51.26 Billions.

The company employs approximately 107.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Abbott Laboratories reported $44.33 Billions in revenue, generating net income of $6.52 Billions.

Key financial metrics include a P/E ratio of 27.37, a price-to-book (P/B) ratio of 3.48, and a trailing twelve-month dividend yield of 2.34%.

The company trades under the ticker ABT.

Market cap

$ 178.54 Billions

Net worth

$ 51.26 Billions

$ 51,264,000,000.00

Assets

$ -

Total Shares Outstanding

1.74 Billion

1,739,000,000

Average Daily Trading Volume

$ 12.47 Millions

$ 12,472,290.90

Sector

Health

Industry

Medical Supplies and Equipment

ABT

revenue by Business Segment Abbott

Revenue by Region Abbott

ABT revenue and profits

Financial Results ABT

DRAG THE FRAME TO SEE MORE DATA

ABT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.16 20,24% (12 M)

P/L

52.79

3.62%

ROE

2.35%

P/VP

1.24

CI - Cigna

$ 278.37 --13,14% (12 M)

P/L

10.45

2.26%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 37.27 --40,26% (12 M)

P/L

-2.59

0.00%

ROE

-33.28%

P/VP

0.86

HUM - Humana

$ 197.45 --30,67% (12 M)

P/L

17.96

1.99%

ROE

6.70%

P/VP

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12 M)

P/L

15.86

0.62%

ROE

-244.82%

P/VP

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12 M)

P/L

40.57

0.67%

ROE

86.53%

P/VP

35.11

NVS - Novartis

$ 155.47 58,82% (12 M)

P/L

21.09

4.53%

ROE

30.04%

P/VP

6.34

Frequently Asked Questions

What is the price of Abbott (ABT) today?

The current price of Abbott (ABT) is $ 102.93, representing a -16.95% gain over the past year. The stock began the year trading around $ 125.29 and is currently priced at $ 102.93. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Abbott (ABT) pay dividends?

In the last year, Abbott (ABT) distributed dividends in the month of February, totaling $ 0.63. The Dividend Yield for the last 12 months is 2.34%.

Is Abbott (ABT) a good investment?

Abbott (ABT) is currently trading at $ 102.93 with a P/E ratio of 27.37%. This represents a 2,479% premium compared to its historical average P/E. Over the past year, the stock has gained -16.95 and paid $ 0.63 in dividends, resulting in a dividend yield of 2.34%. The total shareholder return over the same period was -16.95%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Abbott (ABT) stock?

You can buy Abbott (ABT) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ABT and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Abbott (ABT) yield today?

Over the past month, Abbott (ABT) has returned -6.32% — -16.95% over the past year, and -6.24% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 2.40 per share in dividends, resulting in a dividend yield of 2.34%.

If you were to purchase 100 shares of Abbott (ABT) today at the current price of $ 102.93 your total investment would be $ 10,292.50.

Based on historical performance, the investment would have grown to approximately:

$ 8,547.92 after 1 year
$ 9,650.25 after 5 years
$ 30,007.78 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ABT

Abbott Laboratories

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ABT

review the fundamentals of Abbott shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 2.34%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Abbott

Abbott Laboratories

United States

126 years

1949

107.000

History and Development

Additional Information

PROFIT X PRICE ABT

Financial Results ABT

ABT cash flow

Asset, Revenue and Profit Growth - ABT

ABT balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions